Sagres Discovery Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$11.8M
Sagres Discovery General Information
Description
Provider of oncogene discovery, individualized cancer profiling, drug target validation and therapeutic development.
Contact Information
Website
www.sagres-discovery.comCorporate Office
- 2795 Second Street
- Suite 400
- Davis, CA 95616
- United States
Corporate Office
- 2795 Second Street
- Suite 400
- Davis, CA 95616
- United States
Sagres Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 06-Jul-2004 | $11.8M | Completed | Product Development | ||
| 3. Early Stage VC | 22-Dec-2003 | Completed | Product Development | |||
| 2. Early Stage VC (Series B) | 03-Oct-2001 | $20M | $21.1M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | $1.06M | $1.06M | Completed | Product Development |
Sagres Discovery Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Sagres Discovery Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sagres Discovery Patents
Sagres Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2006235260-A1 | Adam10 in cancer diagnosis, detection and treatment | Inactive | 07-Apr-2005 | ||
| CA-2604883-A1 | Adam10 in cancer diagnosis, detection and treatment | Inactive | 07-Apr-2005 | ||
| EP-1896580-A2 | Adam10 in cancer diagnosis, detection and treatment | Inactive | 07-Apr-2005 | ||
| US-20090297507-A1 | Adam10 in cancer diagnosis, detection and treatment | Inactive | 07-Apr-2005 | ||
| WO-2006110583-A2 | Adam10 in cancer diagnosis, detection and treatment | Inactive | 07-Apr-2005 | C12N15/1137 |
Sagres Discovery Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axiom Venture Partners | Venture Capital | Minority | ||
| Blue Dot Capital | Corporate Venture Capital | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| CDIB Capital Group | Asset Manager | Minority | ||
| Forward Ventures | Venture Capital | Minority |
Sagres Discovery Acquisitions (1)
Sagres Discovery’s most recent deal was a Merger/Acquisition with MemRx. The deal was made on 02-Apr-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MemRx | 02-Apr-2003 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Sagres Discovery FAQs
-
When was Sagres Discovery founded?
Sagres Discovery was founded in 2000.
-
Where is Sagres Discovery headquartered?
Sagres Discovery is headquartered in Davis, CA.
-
What industry is Sagres Discovery in?
Sagres Discovery’s primary industry is Drug Discovery.
-
Is Sagres Discovery a private or public company?
Sagres Discovery is a Private company.
-
What is the current valuation of Sagres Discovery?
The current valuation of Sagres Discovery is .
-
What is Sagres Discovery’s current revenue?
The current revenue for Sagres Discovery is .
-
How much funding has Sagres Discovery raised over time?
Sagres Discovery has raised $22M.
-
Who are Sagres Discovery’s investors?
Axiom Venture Partners, Blue Dot Capital, Burrill & Co, CDIB Capital Group, and Forward Ventures are 5 of 8 investors who have invested in Sagres Discovery.
-
When was Sagres Discovery acquired?
Sagres Discovery was acquired on 06-Jul-2004.
-
Who acquired Sagres Discovery?
Sagres Discovery was acquired by Chiron (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
